EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Edwin B.C. Woo
Augustine T.M. Tang
Ahmed El Gamel
Mark T. Jones
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woo, E. B.C.
Right arrow Articles by Hooper, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, E. B.C.
Right arrow Articles by Hooper, T. L.
Related Collections
Right arrow Anesthesia
Right arrow Cardiac - pharmacology
Right arrow Cardiac - physiology
Right arrow Extracorporeal circulation

Eur J Cardiothorac Surg 2002;22:106-111
© 2002 Elsevier Science NL


Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction?

Edwin B.C. Wooa, Augustine T.M. Tangb, Ahmed El Gamelc, Brian Keevild, Donna Greenhalghe, Mark Patricke, Mark T. Jonesa, Timothy L. Hoopera*

a Department of Cardiothoracic Surgery, Wythenshawe Hospital, Southmoor Road, Manchester, M23 9LT, UK
b Department of Cardiothoracic Surgery, Southampton General Hospital, Southampton, UK
c Department of Cardiothoracic Surgery, King's College London, London, UK
d Department of Chemical Pathology, Wythenshawe Hospital, Manchester, UK
e Department of Anaesthesia, Wythenshawe Hospital, Manchester, UK

Received 13 August 2001; received in revised form 1 April 2002; accepted 3 April 2002.

* Corresponding author. Tel.: +44-161-2912511; fax: +44-161-2912530

Objectives: We aimed to evaluate the renoprotective role of renal-dose dopamine on cardiac surgical patients at high risk of postoperative renal dysfunction. The latter included older patients or those with pre-existing renal disease, elevated preoperative serum creatinine (Cr), poor ventricular function, hypertension, diabetes mellitus and unstable angina requiring intravenous therapy. Methods: Fifty patients undergoing cardiopulmonary bypass (CPB) who fulfilled the entry criteria were prospectively randomized into two groups: Group 1 received a ‘renal-dose’ (3 µg kg-1 min-1) dopamine infusion starting at anaesthetic induction for 48 h whilst saline infusion acted as placebo in Group 2. The anaesthetic and CPB regimes were standardized. Urinary excretion of retinol binding protein (RBP) indexed to Cr, an accurate and sensitive marker of early renal tubular damage, was assessed daily for 6 days. Additional outcome measures included daily fluid balance, blood urea and serum Cr. Statistical comparisons were made using ANOVA and Mann–Whitney U-test. Results: No significant difference was found between the groups in their age, gender, preoperative NYHA class, ejection fraction, baseline serum Cr and duration of CPB and aortic cross-clamping. Renal replacement therapy was not required in any instance. Both groups demonstrated a similar and significant rise in urinary RBP throughout the study period. Dopamine-treated patients achieved more negative average fluid balance than those on placebo (5 vs. 229 ml, P<0.05). Conclusions: Renal-dose dopamine therapy failed to offer additional renoprotection to patients considered at increased risk of renal dysfunction after CPB.

Key Words: Anaesthesia • Blood flow • Cardiopulmonary bypass • Kidney • Vasodilation




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
B. Mahesh, B. Yim, D. Robson, R. Pillai, C. Ratnatunga, and D. Pigott
Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
M. H. Rosner, D. Portilla, and M. D. Okusa
Analytic Reviews: Cardiac Surgery as a Cause of Acute Kidney Injury: Pathogenesis and Potential Therapies
J Intensive Care Med, January 1, 2008; 23(1): 3 - 18.
[Abstract] [PDF]


Home page
PerfusionHome page
Y. Abu-Omar and C. Ratnatunga
Cardiopulmonary Bypass and Renal Injury
Perfusion, July 1, 2006; 21(4): 209 - 213.
[Abstract] [PDF]


Home page
CJASNHome page
M. H. Rosner and M. D. Okusa
Acute Kidney Injury Associated with Cardiac Surgery
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 19 - 32.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
N. Gill, J. V. Nally Jr, and R. A. Fatica
Renal Failure Secondary to Acute Tubular Necrosis: Epidemiology, Diagnosis, and Management
Chest, October 1, 2005; 128(4): 2847 - 2863.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. O. Friedrich, N. Adhikari, M. S. Herridge, and J. Beyene
Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death
Ann Intern Med, April 5, 2005; 142(7): 510 - 524.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.